Orlistat
Study Exploring the Supportive Effect of Acarbose in Weight Management
Empros Pharma AB · Phase 2 · Status n/r · Enrollment 320
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| EMP16-120/40 | Obesity or overweight | n/r | n/r | n/r | n/r |
| MR orlistat | Obesity or overweight | n/r | n/r | n/r | n/r |
| Conventional orlistat | Obesity or overweight | n/r | n/r | n/r | n/r |
| EMP16-60/20 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |